Dr Lalchandani Labs Ltd. (DLCL) — Tipsheet

Dr Lalchandani Labs posts profit only because lenders waived ₹61 lacs in debt

Tipsheet Editorial — Wed, 03 Jun 2026 21:40:16 GMT

Auditors qualified the accounts, flagging NPA classification and unpaid statutory dues since mid-2024. The company holds ₹4.14 cr in cash but won't pay.

What’s new

FY26 net profit of ₹6.35 lacs rests entirely on a ₹61.08 lacs one-time settlement gain from loan waivers.
Auditors issued a qualified opinion: accounts are NPA-classified, loans are in default, and statutory dues (PF, TDS) are unpaid since July 2024.
The company holds ₹4.14 cr cash but has not paid these dues or provided for ₹-- gratuity/leave liabilities.

Why it matters

A qualified audit opinion is a red flag; an NPA classification with defaulted loans is a crisis. The fact that the company reports positive cash yet refuses to pay statutory dues suggests a deliberate cash-preservation strategy at the expense of employees and tax authorities. This is not a company in turnaround. It is a company in distress, managing a cash squeeze by prioritizing survival over compliance.

What we’re watching

Whether lenders initiate formal recovery proceedings given the NPA classification.
If statutory authorities (PF, TDS) take enforcement action for the long-overdue dues.
The next quarter's cash position and any further qualification on going-concern.

The full read

Dr Lalchandani Labs' audited FY26 results read like a distress memo. The headline number, a net profit of ₹6.35 lacs, is an accounting fiction. It exists solely because lenders wrote off ₹61.08 lacs in a one-time settlement. The auditors' report tells the real story: the company's accounts are classified as NPA, it has defaulted on loans, and it has not paid statutory dues like Provident Fund or TDS since July 2024. This is while it sits on ₹4.14 crore in cash. The board also swapped the monitoring agency for its rights issue proceeds, replacing Infomerics with Brickwork Ratings, without explanation. For a nano-cap company, the pattern is clear: a cash pile exists, but it is not being used to satisfy employees, the taxman, or creditors. The profit is a mirage; the qualifications are the reality.

Primary source: BSE · NSE

Lalchandani Labs auditors flag defaults despite cash reserves

Tipsheet Editorial — Wed, 03 Jun 2026 21:31:49 GMT

Auditors issued a qualified opinion on FY26 results, documenting loan defaults and missed statutory dues even as the company held cash.

What’s new

Auditors issued a qualified opinion, noting defaults on principal and interest despite the company holding significant cash.
Lenders have classified the company's accounts as Non-Performing Assets (NPAs).
Statutory dues including Provident Fund and TDS have not been deposited since July 2024.

Why it matters

The qualified opinion, NPA classification, and unpaid statutory dues point to a company that is either unable or unwilling to meet its obligations. Profitability on paper is irrelevant when the business cannot service its debt or pay its workers' statutory contributions.

What we’re watching

Whether lenders initiate formal recovery proceedings after the NPA classification.
If the new monitoring agency, Brickwork Ratings, flags issues with the rights issue proceeds.
How the company plans to clear the backlog of unpaid statutory dues.

The full read

Dr Lalchandani Labs reported a net profit of ₹6.35 lakh for FY26, but the number is secondary to the qualified audit opinion behind it. Auditors documented defaults on loan principal and interest while the company held significant cash. Lenders responded by classifying the accounts as NPAs. Separately, the company has not deposited Provident Fund or TDS since July 2024. The board also replaced Infomerics with Brickwork Ratings as the monitoring agency for its recent rights issue proceeds. The company did record a ₹61.08 lakh gain from a debt settlement on unsecured loans. The core issue is not the loss of money but the refusal or inability to deploy available cash to meet basic obligations.

Primary source: BSE · NSE

Dr Lalchandani Labs survives on a one-time settlement. Auditors qualify the accounts.

Tipsheet Editorial — Wed, 03 Jun 2026 21:31:39 GMT

A ₹61.08 lacs one-time settlement gain is the only thing standing between the company and an operational loss. Auditors flagged NPA classification and unpaid statutory dues.

What’s new

FY26 net profit collapsed to ₹6.35 lacs from ₹41.72 lacs the prior year.
The company would have posted an operational loss without a ₹61.08 lacs one-time settlement gain.
Auditors issued a qualified opinion citing NPA classification, loan defaults, and unpaid statutory dues.

Why it matters

Dr Lalchandani's reported profit is an accounting artifact, not an operating result. The company's accounts are classified as NPAs, it has defaulted on loans while holding cash, and has not paid statutory dues like Provident Fund and TDS since July 2024. For a firm valued at roughly ₹9 crore, these are not minor governance gaps.

What we’re watching

Whether the company clears the defaulted loan repayments and statutory dues.
SEBI's response to the qualified audit opinion and NPA status.
The impact on the company's ability to secure future financing.

The full read

Dr Lalchandani Labs reported a FY26 net profit of ₹6.35 lacs. Without a ₹61.08 lacs gain from a one-time settlement with lenders, the company would have lost money. The profit is a fiction of the settlement, not the core business. The auditors made this explicit by issuing a qualified opinion. They flagged that the company's accounts are classified as NPAs, that it has defaulted on loan repayments, and that it hasn't paid statutory dues like Provident Fund and TDS since July 2024. The company is a nano-cap valued at roughly ₹9 crore, but the audit trail points to fundamental operational and compliance failures. The reported profit masks a business that cannot sustain itself without exceptional items and has broken its obligations to both lenders and regulators.

Primary source: BSE · NSE